{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:27:19Z","timestamp":1794346039532,"version":"4.9.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH279"],"award-info":[{"award-number":["ZR2020QH279"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018532","name":"Major Scientific and Technological Innovation Project of Shandong Province","doi-asserted-by":"publisher","award":["2021CXGC011105"],"award-info":[{"award-number":["2021CXGC011105"]}],"id":[{"id":"10.13039\/501100018532","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taishan scholar program of Shandong Province","award":["tsqn202306346"],"award-info":[{"award-number":["tsqn202306346"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-01324-4","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T10:39:50Z","timestamp":1747651190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Identification of a panel of volatile organic compounds in urine for early detection of for bladder cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Mai","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"1324_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107871","author":"P Jain","year":"2021","unstructured":"Jain, P., Kathuria, H. & Momin, M. Clinical therapies and nano drug delivery systems for urinary bladder cancer. Pharmacol. Ther. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107871 (2021).","journal-title":"Pharmacol. Ther."},{"key":"1324_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.hoc.2021.02.004","volume":"35","author":"H Ahmadi","year":"2021","unstructured":"Ahmadi, H., Duddalwar, V. & Daneshmand, S. Diagnosis and staging of bladder Cancer. Hematol. Oncol. Clin. N. Am. 35, 531\u2013541. https:\/\/doi.org\/10.1016\/j.hoc.2021.02.004 (2021).","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"1324_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814374","author":"GV Flores Monar","year":"2023","unstructured":"Flores Monar, G. V., Reynolds, T., Gordon, M., Moon, D. & Moon, C. Molecular markers for bladder Cancer screening: An insight into bladder cancer and FDA-approved biomarkers. Int. J. Mol. Sci.  https:\/\/doi.org\/10.3390\/ijms241814374 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1324_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01399-3","author":"S Qiu","year":"2023","unstructured":"Qiu, S. et al. Small molecule metabolites: Discovery of biomarkers and therapeutic targets. Signal. Transduct. Target. Therapy https:\/\/doi.org\/10.1038\/s41392-023-01399-3 (2023).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"1324_CR5","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/8\/3\/034001","author":"A Amann","year":"2014","unstructured":"Amann, A. et al. The human volatilome: Volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva. J. Breath Res. https:\/\/doi.org\/10.1088\/1752-7155\/8\/3\/034001 (2014).","journal-title":"J. Breath Res."},{"key":"1324_CR6","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/apt.15140","volume":"49","author":"A Bond","year":"2019","unstructured":"Bond, A. et al. Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer. Aliment. Pharmacol. Ther. 49, 1005\u20131012. https:\/\/doi.org\/10.1111\/apt.15140 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"1324_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.lungcan.2009.03.029","volume":"67","author":"G ong","year":"2010","unstructured":"ong, G. et al. Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer 67, 227\u2013231. https:\/\/doi.org\/10.1016\/j.lungcan.2009.03.029 (2010).","journal-title":"Lung Cancer"},{"key":"1324_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cca.2012.08.016","volume":"414","author":"A Zhang","year":"2012","unstructured":"Zhang, A., Sun, H., Wu, X. & Wang, X. Urine metabolomics. Clin. Chim. Acta 414, 65\u201369. https:\/\/doi.org\/10.1016\/j.cca.2012.08.016 (2012).","journal-title":"Clin. Chim. Acta"},{"key":"1324_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143283","author":"FL Chan","year":"2015","unstructured":"Chan, F. L. et al. Urinary volatile organic compounds for the detection of prostate Cancer. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0143283 (2015).","journal-title":"PLoS ONE"},{"key":"1324_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108750","author":"K Xie","year":"2014","unstructured":"Xie, K. et al. Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0108750 (2014).","journal-title":"PLoS ONE"},{"key":"1324_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26092447","author":"AS Bannaga","year":"2021","unstructured":"Bannaga, A. S., Tyagi, H., Daulton, E., Covington, J. A. & Arasaradnam, R. P. Exploratory study using urinary volatile organic compounds for the detection of hepatocellular carcinoma. Molecules  https:\/\/doi.org\/10.3390\/molecules26092447 (2021).","journal-title":"Molecules"},{"key":"1324_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2020.121604","author":"E Daulton","year":"2021","unstructured":"Daulton, E. et al. Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine. Talanta https:\/\/doi.org\/10.1016\/j.talanta.2020.121604 (2021).","journal-title":"Talanta"},{"key":"1324_CR13","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/carcin\/bgs026","volume":"33","author":"JM Yuan","year":"2012","unstructured":"Yuan, J. M. et al. Urinary levels of volatile organic carcinogen and toxicant biomarkers in relation to lung cancer development in smokers. Carcinogenesis 33, 804\u2013809. https:\/\/doi.org\/10.1093\/carcin\/bgs026 (2012).","journal-title":"Carcinogenesis"},{"key":"1324_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45989-1","author":"Q Liu","year":"2023","unstructured":"Liu, Q. et al. Identification of urinary volatile organic compounds as a potential non-invasive biomarker for esophageal cancer. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-023-45989-1 (2023).","journal-title":"Sci. Rep."},{"key":"1324_CR15","doi-asserted-by":"publisher","unstructured":"Tyagi, H., Daulton, E., Bannaga, A. S., Arasaradnam, R. P. & Covington, J. A. Non-invasive detection and staging of colorectal cancer using a portable electronic nose. Sensors  https:\/\/doi.org\/10.3390\/s21165440  (2021).","DOI":"10.3390\/s21165440"},{"key":"1324_CR16","doi-asserted-by":"publisher","first-page":"124767","DOI":"10.1016\/j.talanta.2023.124767","volume":"265","author":"T Le","year":"2023","unstructured":"Le, T. & Priefer, R. Detection technologies of volatile organic compounds in the breath for cancer diagnoses. Talanta 265, 124767. https:\/\/doi.org\/10.1016\/j.talanta.2023.124767 (2023).","journal-title":"Talanta"},{"key":"1324_CR17","doi-asserted-by":"publisher","first-page":"121604","DOI":"10.1016\/j.talanta.2020.121604","volume":"221","author":"E Daulton","year":"2021","unstructured":"Daulton, E. et al. Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine. Talanta 221, 121604. https:\/\/doi.org\/10.1016\/j.talanta.2020.121604 (2021).","journal-title":"Talanta"},{"key":"1324_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.chroma.2007.10.110","volume":"1177","author":"AB Kanu","year":"2008","unstructured":"Kanu, A. B. & Hill, H. H. Ion mobility spectrometry detection for gas chromatography. J. Chromatogr. A. 1177, 12\u201327. https:\/\/doi.org\/10.1016\/j.chroma.2007.10.110 (2008).","journal-title":"J. Chromatogr. A"},{"key":"1324_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/joim.12822","volume":"284","author":"GS Handelman","year":"2018","unstructured":"Handelman, G. S. et al. eDoctor: Machine learning and the future of medicine. J. Intern. Med. 284, 603\u2013619. https:\/\/doi.org\/10.1111\/joim.12822 (2018).","journal-title":"J. Intern. Med."},{"key":"1324_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/17460441.2019.1549033","volume":"14","author":"VG Maltarollo","year":"2019","unstructured":"Maltarollo, V. G., Kronenberger, T., Espinoza, G. Z., Oliveira, P. R. & Honorio, K. M. Advances with support vector machines for novel drug discovery. Expert Opin. Drug Discov. 14, 23\u201333. https:\/\/doi.org\/10.1080\/17460441.2019.1549033 (2019).","journal-title":"Expert Opin. Drug Discov."},{"key":"1324_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12911-019-1004-8","volume":"19","author":"S Uddin","year":"2019","unstructured":"Uddin, S., Khan, A., Hossain, M. E. & Moni, M. A. Comparing different supervised machine learning algorithms for disease prediction. BMC Med. Inf. Decis. Mak. 19, 281. https:\/\/doi.org\/10.1186\/s12911-019-1004-8 (2019).","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"1324_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.media.2017.08.004","volume":"42","author":"VA Zimmer","year":"2017","unstructured":"Zimmer, V. A. et al. Learning and combining image neighborhoods using random forests for neonatal brain disease classification. Med. Image Anal. 42, 189\u2013199. https:\/\/doi.org\/10.1016\/j.media.2017.08.004 (2017).","journal-title":"Med. Image Anal."},{"key":"1324_CR23","doi-asserted-by":"publisher","unstructured":"Chen, T. et al. Random forest in clinical metabolomics for phenotypic discrimination and biomarker selection. Evid Based Complement Alternat Med. 298183 (2013). https:\/\/doi.org\/10.1155\/2013\/298183 (2013).","DOI":"10.1155\/2013\/298183"},{"key":"1324_CR24","doi-asserted-by":"publisher","unstructured":"Catala, A. Five decades with polyunsaturated Fatty acids: Chemical synthesis, enzymatic formation, lipid peroxidation and its biological effects. J. Lipids 710290 (2013). https:\/\/doi.org\/10.1155\/2013\/710290 (2013).","DOI":"10.1155\/2013\/710290"},{"key":"1324_CR25","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.freeradbiomed.2007.07.012","volume":"43","author":"U Nair","year":"2007","unstructured":"Nair, U., Bartsch, H. & Nair, J. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: A review of published adduct types and levels in humans. Free Radic. Biol. Med. 43, 1109\u20131120. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2007.07.012 (2007).","journal-title":"Free Radic. Biol. Med."},{"key":"1324_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskjot","year":"2023","unstructured":"Dyrskjot, L. et al. Bladder cancer. Nat. Rev. Dis. Primers 9, 58. https:\/\/doi.org\/10.1038\/s41572-023-00468-9 (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1324_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.redox.2014.12.011","volume":"4","author":"H Zhong","year":"2015","unstructured":"Zhong, H. & Yin, H. Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: Focusing on mitochondria. Redox Biol. 4, 193\u2013199. https:\/\/doi.org\/10.1016\/j.redox.2014.12.011 (2015).","journal-title":"Redox Biol."},{"key":"1324_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/03602532.2018.1555587","volume":"51","author":"A Ahmed Laskar","year":"2019","unstructured":"Ahmed Laskar, A. & Younus, H. Aldehyde toxicity and metabolism: The role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis. Drug Metab. Rev. 51, 42\u201364. https:\/\/doi.org\/10.1080\/03602532.2018.1555587 (2019).","journal-title":"Drug Metab. Rev."},{"key":"1324_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41569-023-00839-5","volume":"20","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. The role of aldehyde dehydrogenase 2 in cardiovascular disease. Nat. Rev. Cardiol. 20, 495\u2013509. https:\/\/doi.org\/10.1038\/s41569-023-00839-5 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"1324_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007487","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Aldehyde dehydrogenase 2-mediated aldehyde metabolism promotes tumor immune evasion by regulating the NOD\/VISTA axis. J. Immunother Cancer  https:\/\/doi.org\/10.1136\/jitc-2023-007487 (2023).","journal-title":"J. Immunother Cancer"},{"key":"1324_CR31","doi-asserted-by":"publisher","first-page":"10122","DOI":"10.1038\/srep10122","volume":"5","author":"Y Masuda","year":"2015","unstructured":"Masuda, Y., Itoh, T., Shin, W. & Kato, K. SnO2 nanosheet\/nanoparticle detector for the sensing of 1-Nonanal gas produced by lung Cancer. Sci. Rep. 5, 10122. https:\/\/doi.org\/10.1038\/srep10122 (2015).","journal-title":"Sci. Rep."},{"key":"1324_CR32","doi-asserted-by":"publisher","first-page":"e0203622","DOI":"10.1128\/aem.02036-22","volume":"89","author":"TMM Sheikh","year":"2023","unstructured":"Sheikh, T. M. M. et al. Volatile organic compounds from pythium oligandrum play a role in its parasitism on plant-pathogenic pythium myriotylum. Appl. Environ. Microbiol. 89, e0203622. https:\/\/doi.org\/10.1128\/aem.02036-22 (2023).","journal-title":"Appl. Environ. Microbiol."},{"key":"1324_CR33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/10715761003667554","volume":"44","author":"GY Liou","year":"2010","unstructured":"Liou, G. Y. & Storz, P. Reactive oxygen species in cancer. Free Radic Res. 44, 479\u2013496. https:\/\/doi.org\/10.3109\/10715761003667554 (2010).","journal-title":"Free Radic Res."},{"key":"1324_CR34","doi-asserted-by":"publisher","first-page":"607904","DOI":"10.3389\/fmolb.2020.607904","volume":"7","author":"A Leiherer","year":"2020","unstructured":"Leiherer, A. et al. The volatilomic footprints of human HGC-27 and CLS-145 gastric Cancer cell lines. Front. Mol. Biosci. 7, 607904. https:\/\/doi.org\/10.3389\/fmolb.2020.607904 (2020).","journal-title":"Front. Mol. Biosci."},{"key":"1324_CR35","doi-asserted-by":"publisher","first-page":"858639","DOI":"10.3389\/fonc.2022.858639","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. A panel of bile volatile organic compounds servers as a potential diagnostic biomarker for gallbladder Cancer. Front. Oncol. 12, 858639. https:\/\/doi.org\/10.3389\/fonc.2022.858639 (2022).","journal-title":"Front. Oncol."},{"key":"1324_CR36","doi-asserted-by":"publisher","first-page":"e16686","DOI":"10.1016\/j.heliyon.2023.e16686","volume":"9","author":"Q Liu","year":"2023","unstructured":"Liu, Q. et al. Volatile organic compounds for early detection of prostate cancer from urine. Heliyon 9, e16686. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16686 (2023).","journal-title":"Heliyon"},{"key":"1324_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28165990","author":"L Mezmale","year":"2023","unstructured":"Mezmale, L. et al. Identification of volatile markers of colorectal Cancer from tumor tissues using volatilomic approach. Molecules https:\/\/doi.org\/10.3390\/molecules28165990 (2023).","journal-title":"Molecules"},{"key":"1324_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/ojapo.2019.81001","volume":"8","author":"K Rios","year":"2019","unstructured":"Rios, K., V\u00e9lez, C. & Zayas, B. Cell death effects of the phthalate 2-ethyl-1-hexanol on human linfoblast cells. Open. J. Apoptosis 8, 1\u201315. https:\/\/doi.org\/10.4236\/ojapo.2019.81001 (2019).","journal-title":"Open. J. Apoptosis"},{"key":"1324_CR39","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1158\/1541-7786.Mcr-17-0784","volume":"16","author":"C Ringuette Goulet","year":"2018","unstructured":"Ringuette Goulet, C. et al. Exosomes induce fibroblast differentiation into Cancer-Associated fibroblasts through TGF\u03b2 signaling. Mol. Cancer Res. 16, 1196\u20131204. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-17-0784 (2018).","journal-title":"Mol. Cancer Res."},{"key":"1324_CR40","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.molmed.2013.05.004","volume":"19","author":"S Madar","year":"2013","unstructured":"Madar, S., Goldstein, I. & Rotter, V. Cancer associated fibroblasts\u2019--more than meets the eye. Trends Mol. Med. 19, 447\u2013453. https:\/\/doi.org\/10.1016\/j.molmed.2013.05.004 (2013).","journal-title":"Trends Mol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01324-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01324-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01324-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T10:39:51Z","timestamp":1747651191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01324-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1324"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01324-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of Qilu Hospital of Shandong University. The study was carried out in accordance with the Declaration of Helsinki. The patients\/participants provided their written informed consent to participate in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"17383"}}